Brown Vance R

Brown Vance R., serving as Senior Vice President, General Counsel, and Corporate Secretary at Boston Scientific (BSX), has filed 43 Form 4 transactions that collectively reveal a pronounced selling posture with no offsetting open-market purchases. The total value of sales reached approximately $3.5 million, while the buy-side value stood at zero. The most recent activity, however, is dominated by automatic and mechanical events rather than discretionary trades. In February 2026, the filings show a cluster of option exercises (code M) paired with shares withheld to cover tax obligations (code F), including a substantial $955,946.16 withholding on February 13, alongside smaller tax-related withholdings of $66,509.70 and $66,883.35 on February 14 and 16, respectively. These transactions, along with several grants (code A) in mid-February, are compensation-related and do not represent a directional bet by the insider. The discretionary selling pattern is clearer in the earlier filings. On March 21, 2025, Brown sold BSX shares worth $486,702.10, and a month earlier, on February 21, 2025, sold another $504,992.64. These two open-market sales (code S) account for roughly $991,694.74 of the total sell value, indicating a deliberate reduction of equity exposure over a four-week span. The remaining sell-side volume stems from tax-withholding events (code F) tied to equity vesting, such as the $204,530.56 withholding on July 1, 2025, and various smaller amounts in February 2025. No purchases (code P) or acquisitions (code A with value) appear in the record, reinforcing that Brown’s activity is entirely one-directional: selling or mechanically disposing of shares, with no recent open-market buying to suggest accumulation. Trading in BSX has been consistent in its mechanics but not in its timing. The February 2026 filings show a heavy concentration of option exercises and tax withholdings clustered around the vesting period, with the largest single event—the $955,946.16 tax withholding—occurring on February 13, 2026. This contrasts with the discretionary sales of early 2025, which were spaced roughly a month apart. The absence of any buy-side transactions across the entire 43-trade history, combined with the recent reliance on automatic code F and M events, suggests that Brown’s net position in BSX is declining, driven by both planned sales and the involuntary mechanics of equity compensation. The data does not indicate any recent open-market purchases, leaving the insider’s bias firmly in the sell column.